TMDX TransMedics Group, Inc.
Healthcare$69.85+0.00%OpenMarket Cap: $2.41B
As of 2026-05-26
Valuation
P/E (TTM)
19.35
PEG
0.04
P/B
4.80
P/S
3.75
EV/EBITDA
19.94
DCF Value
$-1,150.76
FCF Yield
6.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.1%
Operating Margin
14.9%
Net Margin
27.0%
ROE
41.9%
ROA
12.0%
ROIC
6.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $173.9M | 58.2% | $13.3M | $7.3M | $— | — |
| Q4 null | $160.8M | 58.1% | $21.3M | $105.4M | $— | — |
| FY null | $605.5M | 59.9% | $108.6M | $190.3M | $— | — |
| Q3 null | $143.8M | 58.8% | $23.3M | $24.3M | $— | — |
| Q2 null | $157.4M | 61.4% | $36.6M | $34.9M | $— | — |
| Q1 null | $143.5M | 61.5% | $27.4M | $25.7M | $— | — |
| Q4 null | $121.6M | 59.2% | $8.6M | $6.9M | $— | — |
| FY null | $441.5M | 59.4% | $37.5M | $35.5M | $— | — |
| Q3 null | $108.8M | 55.9% | $3.9M | $4.2M | $— | — |
| Q2 null | $114.3M | 60.5% | $12.5M | $12.2M | $— | — |
| Q1 null | $96.8M | 61.8% | $12.4M | $12.2M | $— | — |
| Q4 2023 | $81.2M | 59.0% | $2.6M | $4.0M | $0.12 | — |